Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

Dow Inc.

DOW

NEUTRAL

May 27, 2026

Research Conclusion

HOLD-ACCUMULATE — Moderate-Low Conviction. Dow is a deep-trough commodity polyethylene chemicals cyclical: FY25 revenue $40B (vs. $57B peak); $2.6B net loss; FCF -$1.5B; 9% dividend yield arithmetically unsustainable. At ~$39 vs. mid-cycle PWFV $40-50, modest +3-28% upside. The 9% dividend yield is a risk signal, not value. Position 1-3% as cyclical recovery bet; aggressive add only below $30.

Company Overview & Moat Assessment

Dow Inc. (NYSE: DOW) is a commodity polyethylene (PE) chemicals producer with global operations across three segments: Packaging & Specialty Plastics (~55%), Industrial Intermediates & Infrastructure, and Performance Materials & Coatings. FY2025 trough: revenue $40B (-30% from peak), net loss $2.6B, FCF -$1.5B. Path2Zero Alberta project ($5B net capex) paused. CEO Jim Fitterling. Net debt $15.8B / 14x EBITDA at trough. 9% dividend yield ($2.80/share, $2B annual cost) uncovered by FCF.

▲ Bull Case

  • ◆PE cycle recovery FY27: Spreads recover to $350-450/MT; EBITDA $5.5-7B; multiple 7-8x → $60-80 (+54-105%)
  • ◆European rationalization: $500M-1B annual EBITDA structural lift → +$10-15/share
  • ◆Path2Zero restart at right cycle: +$10-15/share by 2030 (not currently priced)

▼ Bear Case

  • ◆Extended Chinese overcapacity: EBITDA $2-3B; dividend suspended; equity to $25-30 → -23-36%
  • ◆Dividend cut: Income investors exit; multiple compresses → -10-18%
  • ◆Credit downgrade + debt spiral: Pension + interest costs spike → -23-36%
Primary Debate on Wall Street

“Bulls: Cycle trough + mid-cycle recovery + dividend support = value. Bears: Chinese structural overcapacity + uncovered dividend = value trap. Decision-margin: Chinese capacity utilization normalization timing.”

Top Catalysts
  • ◆Q2-Q3 FY26 EBITDA trajectory — HIGH magnitude upside if recovery materializes
  • ◆Dividend cut announcement — HIGH sentiment impact, likely sell-off
  • ◆European rationalization announcement FY26-FY27 — MEDIUM-HIGH upside
  • ◆PE spread direction (monthly) — EXTREME volatility driver
  • ◆Path2Zero restart commentary FY27-FY28 — MEDIUM-HIGH upside optionality
  • ◆Credit rating action — HIGH downside if downgrade
  • ◆Chinese property sector stabilization — HIGH upside if demand recovers
Top Risks
  • ◆Extended Chinese overcapacity (35% probability, EXTREME severity)
  • ◆Dividend cut (60% probability, MEDIUM severity)
  • ◆New US capacity additions (60% probability, MEDIUM severity)
  • ◆Credit downgrade (25% probability, HIGH severity)
  • ◆Recession (25% probability, HIGH severity)
  • ◆Pension/debt spiral (10% probability, EXTREME severity)

Full Memo Continues

5 more sections, locked

  • ●
    Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • ●
    Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • ●
    Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • ●
    Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • ●
    Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/DOW/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.